Trial Profile

A Phase II Trial to Assess the Safety, Immunological Activity of TroVax Plus Pemetrexed/Cisplatin in Patients With Malignant Pleural Mesothelioma

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 14 Jun 2019

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs MVA 5T4 (Primary) ; Cisplatin; Cobalamin; Dexamethasone; Folic acid; Pemetrexed
Indications Malignant-mesothelioma
Focus Adverse reactions; Therapeutic Use
Acronyms SKOPOS

Most Recent Events

13 Nov 2015 Status changed from recruiting to completed, according to United Kingdom Clinical Research Network.
13 Nov 2015 Planned End Date changed from 31 Jul 2015 to 27 Aug 2015, according to United Kingdom Clinical Research Network.
09 Nov 2015 Data from this trial is expected to be published in a peer-reviewed journal in 2016, according to an Oxford BioMedica media release.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com